Literature DB >> 3257442

Presence of immunoreactive corticotropin-releasing factor in rat testis.

D J Yoon1, C Sklar, R David.   

Abstract

We attempted to demonstrate the presence of immunoreactive (ir) CRF in rat testis by RIA, and by an immunocytochemical technique. The RIA was performed on 27,000 x g supernatants of phosphate buffer extracts of adult rat testes, and revealed a high concentration of irCRF (51 - 74 ng/g testis), with a clear parallelism to the standard curve prepared with synthetic rat CRF. In contrast, the peripheral blood level of irCRF was extremely low (less than 0.05 ng/ml). Immunocytochemical studies of irCRF revealed strong specific staining in the Leydig cells and germ cells in normal adult rat testis. Epididymal spermatozoa also stained positive. Testicular irCRF fluctuated significantly with age. The levels (mean +/- SD) assayed in 10, 20, 60 and 90-day-old rats were 41.6 +/- 4.7, 8.7 +/- 0.2, 55.5 +/- 3.3 and 71.3 +/- 3.4 ng/g testis, respectively (P less than 0.01). The level was drastically reduced after abdominal translocation of a testis (9.6 +/- 1.3 ng/g testis), and after hypophysectomy (16.7 +/- 1.6 ng/g testis) in adult rats. However, neither hemicastration nor unilateral cryptorchidism influenced the irCRF levels in the contralateral testis. These data suggest a local production of irCRF which may play a role in regulation of Leydig cell function and sperm maturation in testis and epididymis.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3257442     DOI: 10.1210/endo-122-2-759

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  14 in total

Review 1.  Corticotropin-releasing factor (CRF) and stress-related reproductive failure: the brain as a state of the art or the ovary as a novel clue?

Authors:  R E Nappi; S Rivest
Journal:  J Endocrinol Invest       Date:  1995-12       Impact factor: 4.256

2.  Urocortins are present in the rat testis.

Authors:  Soon Lee; Brian Braden; Sang Soo Kang; Catherine Rivier
Journal:  Neuropeptides       Date:  2011-01-21       Impact factor: 3.286

Review 3.  Human endometrium as a neuroendocrine tissue: expression, regulation and biological roles of endometrial corticotropin-releasing hormone (CRH) and opioid peptides.

Authors:  E Zoumakis; A N Margioris; A Makrigiannakis; C Stournaras; A Gravanis
Journal:  J Endocrinol Invest       Date:  1997-03       Impact factor: 4.256

4.  Immunohistochemical localization of growth hormone-releasing hormone in human gonads.

Authors:  C Moretti; A Fabbri; L Gnessi; V Bonifacio; M Bolotti; M Arizzi; Q Nazzicone; G Spera
Journal:  J Endocrinol Invest       Date:  1990-04       Impact factor: 4.256

5.  Expression of the mouse corticotropin-releasing hormone gene in vivo and targeted inactivation in embryonic stem cells.

Authors:  L J Muglia; N A Jenkins; D J Gilbert; N G Copeland; J A Majzoub
Journal:  J Clin Invest       Date:  1994-05       Impact factor: 14.808

6.  Identification of a second corticotropin-releasing factor receptor gene and characterization of a cDNA expressed in heart.

Authors:  M Perrin; C Donaldson; R Chen; A Blount; T Berggren; L Bilezikjian; P Sawchenko; W Vale
Journal:  Proc Natl Acad Sci U S A       Date:  1995-03-28       Impact factor: 11.205

Review 7.  Physiological and neurochemical aspects of corticotropin-releasing factor actions in the brain: the role of the locus coeruleus.

Authors:  H Lehnert; C Schulz; K Dieterich
Journal:  Neurochem Res       Date:  1998-08       Impact factor: 3.996

Review 8.  Neuropeptides of the pituitary adenylate cyclase-activating polypeptide/vasoactive intestinal polypeptide/growth hormone-releasing hormone/secretin family in testis.

Authors:  Min Li; Akira Arimura
Journal:  Endocrine       Date:  2003-04       Impact factor: 3.633

9.  Immunoreactive corticotropin-releasing hormone and its binding sites in the rat ovary.

Authors:  G Mastorakos; E L Webster; T C Friedman; G P Chrousos
Journal:  J Clin Invest       Date:  1993-08       Impact factor: 14.808

10.  Presence of immunoreactive corticotropin releasing hormone in thyroid lesions.

Authors:  C D Scopa; G Mastorakos; T C Friedman; M Melachrinou; M J Merino; G P Chrousos
Journal:  Am J Pathol       Date:  1994-11       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.